A framework for personalized medicine: prediction of drug sensitivity in cancer by proteomic profiling

BACKGROUND: The goal of personalized medicine is to provide patients optimal drug screening and treatment based on individual genomic or proteomic profiles. Reverse-Phase Protein Array (RPPA) technology offers proteomic information of cancer patients which may be directly related to drug sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong-Chul, Wang, Xiaoyu, Yang, Chin-Rang, Gao, Jean X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Proceedings
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380735/
https://www.ncbi.nlm.nih.gov/pubmed/22759571
http://dx.doi.org/10.1186/1477-5956-10-S1-S13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380735/
https://www.ncbi.nlm.nih.gov/pubmed/22759571
http://dx.doi.org/10.1186/1477-5956-10-S1-S13

Ejemplares similares